Total Payments
$14,277
2024 Payments
$880.31
Companies
54
Transactions
944
Medicare Patients
940
Medicare Billing
$167,278
Payment Breakdown by Category
Food & Beverage$14,178 (99.3%)
Education$99.41 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,178 | 929 | 99.3% |
| Education | $99.41 | 15 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,849 | 146 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,433 | 86 | $0 (2024) |
| Lilly USA, LLC | $1,272 | 80 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,260 | 75 | $0 (2024) |
| Amgen Inc. | $1,211 | 62 | $0 (2024) |
| ABBVIE INC. | $980.65 | 76 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $701.91 | 47 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $571.27 | 41 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $537.41 | 30 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $522.73 | 33 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $880.31 | 38 | AstraZeneca Pharmaceuticals LP ($243.23) |
| 2023 | $876.47 | 56 | AbbVie Inc. ($225.28) |
| 2022 | $1,501 | 97 | Novartis Pharmaceuticals Corporation ($214.87) |
| 2021 | $2,437 | 159 | Novo Nordisk Inc ($463.16) |
| 2020 | $1,760 | 115 | Novo Nordisk Inc ($309.66) |
| 2019 | $2,093 | 146 | Novo Nordisk Inc ($367.54) |
| 2018 | $2,066 | 153 | Amgen Inc. ($316.33) |
| 2017 | $2,663 | 180 | Lilly USA, LLC ($420.89) |
All Payment Transactions
944 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Oncology | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Inflammation | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Respiratory | ||||||
| 07/24/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.69 | General |
| 07/10/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 06/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: RESPIRATORY | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/21/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.26 | General |
| Category: Bone Health | ||||||
| 05/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 191 | 573 | $103,230 | $46,746 |
| 2022 | 4 | 228 | 557 | $94,800 | $42,985 |
| 2021 | 4 | 239 | 541 | $86,510 | $39,038 |
| 2020 | 6 | 282 | 646 | $94,530 | $38,509 |
Total Patients
940
Total Services
2,317
Medicare Billing
$167,278
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 450 | $67,500 | $34,713 | 51.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 70 | 70 | $28,000 | $8,408 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 41 | $5,330 | $2,556 | 48.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $2,400 | $1,069 | 44.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 395 | $59,250 | $31,423 | 53.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 71 | 71 | $28,400 | $8,604 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 52 | $6,760 | $2,843 | 42.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 35 | 39 | $390.00 | $115.62 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 353 | $52,950 | $27,030 | 51.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 56 | 56 | $22,400 | $7,000 | 31.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 82 | $10,660 | $4,858 | 45.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 42 | 50 | $500.00 | $150.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 103 | 412 | $61,800 | $27,488 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 40 | 40 | $16,000 | $4,361 | 27.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 51 | 84 | $10,920 | $4,351 | 39.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 24 | $4,800 | $1,960 | 40.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 56 | 71 | $710.00 | $211.92 | 29.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2020 | 11 | 15 | $300.00 | $136.71 | 45.6% |
About Dr. Ali Dohan, M.D
Dr. Ali Dohan, M.D is a Internal Medicine healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558457432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali Dohan, M.D has received a total of $14,277 in payments from pharmaceutical and medical device companies, with $880.31 received in 2024. These payments were reported across 944 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($14,178).
As a Medicare-enrolled provider, Dohan has provided services to 940 Medicare beneficiaries, totaling 2,317 services with total Medicare billing of $167,278. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Indianapolis, IN
- Active Since 10/05/2006
- Last Updated 09/02/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558457432
Products in Payments
- TRELEGY ELLIPTA (Drug) $886.36
- FARXIGA (Drug) $837.94
- Ozempic (Drug) $674.31
- VRAYLAR (Drug) $644.32
- ENTRESTO (Drug) $627.99
- Repatha (Biological) $477.29
- ELIQUIS (Drug) $476.56
- XARELTO (Drug) $469.67
- JARDIANCE (Drug) $465.66
- TRULICITY (Drug) $441.37
- Livalo (Drug) $398.28
- Victoza (Drug) $328.36
- Vascepa (Drug) $269.03
- BREZTRI (Drug) $268.92
- LINZESS (Drug) $251.20
- Aimovig (Biological) $231.54
- VIBERZI (Drug) $222.00
- MOUNJARO (Drug) $210.47
- EVENITY (Biological) $205.46
- SOLIQUA 100/33 (Biological) $174.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Indianapolis
Rafat Abonour, Md, MD
Internal Medicine — Payments: $833,709
Internal Medicine $833,709
David Batt, Md, MD
Internal Medicine — Payments: $682,018
Internal Medicine $682,018
Ashwin Ravichandran, Md, MD
Internal Medicine — Payments: $398,583
Internal Medicine $398,583
John Miller, Md, MD
Internal Medicine — Payments: $325,524
Internal Medicine $325,524
Naga Chalasani, Md, MD
Internal Medicine — Payments: $303,095
Internal Medicine $303,095
James Trippi, Md, MD
Internal Medicine — Payments: $280,481
Internal Medicine $280,481